Visalytics
Visalytics
approved EB-2 (NIW)

Senior Research Associate

Biotechnology · China · 2025-02-15

Processing Time
60 days
Decision Date
2025-02-15
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to use advanced in vitro functional approaches to study disease mechanisms and identify drug targets for cancer, obesity, and autoimmune disorders. Her work specifically focuses on advancing personalized cancer treatments by identifying precise drug targets and improving immune regulation.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical public health challenges including cancer and autoimmune diseases, providing significant value to U.S. healthcare and reducing financial burdens of chronic disease.

2 Well-positioned to Advance the Endeavor Met

The petitioner's background, publication record, and funding from prestigious institutions like the NHLBI and JDRF demonstrate her capability to lead the research.

3 Balance of Interests Met

On balance, the U.S. benefits from waiving the labor certification because the petitioner's work provides unique insights into disease prevention and treatment that would be hindered without her continued work.

Why This Petition Was Approved

The petition was approved based on the petitioner's MS in biology and her authorship of 3 peer-reviewed journal articles and 1 preprint. Despite a citation count of 12, the case was supported by four independent expert recommendation letters and evidence of funding from major organizations like the NHLBI, MSCA, and JDRF. USCIS determined that her research satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Professional Memberships

Similar Cases

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Others

Biotechnology · Hong Kong

WeGreened EB-2 (NIW) approved
Illinois 446 days 2022-08-23
The petitioner proposes to continue research on the behavior of the immune system in skin cancers and identify new mutations that drive their formation. This work aims to develop new therapies against cancer, specifically focusing on molecular mediators of breast cancer metastasis and treatments for autoimmune and inflammatory bowel diseases.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 60 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist